On track to complete enrollment for the Phase 3 PROACT 1 accelerated approval analysis of rilparencel in mid-2026; anticipate ...
Week Study to Evaluate One-Step Dose Titration to 48 mg and Two-Step Dose Titration to 64 mg in Obese Otherwise Healthy Adults CAMBRIDGE, Mass., March 18, 2026 ...
9h
Weibo Announces Fourth Quarter and Fiscal Year 2025 Unaudited Financial Results and Annual Dividend
Weibo Corporation ("Weibo" or the "Company") (Nasdaq: WB and HKEX: 9898), a leading social media in China, today announced its unaudited financial results for the fourth quarter and fiscal year ended ...
Q4 2025 Earnings Call March 18, 2026 5:30 AM EDTCompany ParticipantsJannine Millingham-GroenewaldClifford Elphick - ...
Weibo Corporation ("Weibo" or the "Company") (Nasdaq: WB and HKEX: 9898), a leading social media in China, today announced ...
UCLOUDLINK GROUP INC. (“UCLOUDLINK” or the “Company”) (NASDAQ: UCL), the world’s first and leading mobile data traffic sharing marketplace, today announced its unaudited financial results for the ...
Welcome to InPost Fourth Quarter and Full Year 2025 Earnings Call. A usual disclaimer, today's call includes forward-looking statements that are subject to risks, and it is possible that the actual ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results